Issledovanie ASCOT kak argument v bor'be "novogo" so "starym" i shag k pereotsenke "sistemy tsennostey"


Cite item

Full Text

Abstract

Исследование ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) триумфально финишировало в 2005 г., доказав, что комбинация "новых" антигипертензивных средств - антагонистов кальция и ингибиторов ангиотензинпревращающего фермента (ИАПФ) лучше, чем комбинация "старых" - b-адреноблокаторов и диуретиков.

About the authors

S. A Boytsov

Российский кардиологический научно-производственный комплекс, Москва

References

  1. Culter J, Mac Mahon S, Furberg C. Controlled clinical trials of drug treatment for hypertension: a review. Hypertension 1989; 13: 136-44.
  2. Poulter N, Sever P. Anglo-Scandinavian Cardiac Outcomes Trial. History, results and implications for the management of high blood pressure. Birmingham: Sherborne Gibbs Ltd 2005.
  3. Neal B. Blood Pressure-Lowering Treatment Trialists Collaboration. Lancet 2000; 356: 1956-64.
  4. Blood Pressure-Lowering Treatment Trialists Collaboration. Effects of different blood - pressure - lowering regimens on major cardiovascular events: results of prospectively - designed overviews of randomized trials. Lancet 2003; 362: 1527-45.
  5. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.
  6. Weber M.A. The ALLHAT Report: A case of Information and Misinformation. J Clin Hypertens 2003; 5 (1): 9-13.
  7. Moser M. Results of the ALLHAT Trial: Is the Debate About Initial Antihypertensive Drug Therapy Over? J Clin Hypertens 2003; 5 (1): 5-8.
  8. Dahlof B, Devereux R.B, Kjeldsen S.E et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003.
  9. Schmieder R.E, Schlaich M.P, Klingbeli A.U et al. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta - analysis of all randomaized double - blind studies until December 1996). Nephrol Dial Transplant 1998; 13: 554-69.
  10. Kjeldsen S.E, Dahlof B, Devereux R.B et al. Losartan Intervention for Endpoint Reduction (LIFE) Study Group: Effect of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: Losartan Intervention for Endpoint Reduction (LIFE) substudy. J Am Med Assoc 2002; 288: 1491-8.
  11. Nichols W.W, O'Rourke M.F. Mc Donald's blood flow in arteries: theoretic, experimental and clinical principles. 5th ed. Edward Arnold, London, 2005.
  12. Brown D.W, Giles W.H, Croft J.B. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 2000; 140 (6): 848-56.
  13. London G.M, Asmar R.G, O,Rourke M.F, Safar M.E. REASON Project Investigators: Mechanism(s) of selective systolic blood pressure reduction after a low dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43: 92-9.
  14. Lonn E, Shaikholeslami R, Yi Q, Bosch J et al. Effect of ramipril on left ventricular mass and function in cardiovascular patients wih controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial. J Am Coll Cardiol 2004; 43: 2200-6.
  15. Mahmud A, Feely J. Arterial Stiffness and Antihypertensive Therapy. Expert Rev Cardiov Ther 2003; 1: 65-72.
  16. Tropeano A-I, Boutouyrie P, Pannier B et al. Brachial pressure - independent reduction in carotid stiffnes after long - term angiotensin - convertinge enzyme inhibition in diabetic hypertensives. Hypertension 2006; 48 (1): 80-6.
  17. Nichols W.W. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertension 2005; 18 (1, Part 2): 3S-10S.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2006 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).